Action CaUses cell death by specific inhibition of DNA symthesis. This action caUses regressions in chronic myeloid leukemia and other malignancies and psoriasis. The S-phase-specific action of hydroxyurea can deplete bone marrow precursor cells associated with megaloblastic changes.
Dosage:Adults : Solid tumours Intermittent therapy : 80 mg/kg as single dose every 3 rd day. Continuous therapy : 20-30 mg/kg as single daily Dose Carcinoma of head and neck : 80 mg/kg as a single dose every Yd day. Begin therapy atleast 7 days before initiation of irradiation therapy. Resistant chronic myelocytic leukaemia : Continuous therapy of 20-30 mg/kg as a single daily Dose is recommended.
Capsule
260 EGP
Action CaUses cell death by specific inhibition of DNA symthesis. This action caUses regressions in chronic myeloid leukemia and other malignancies and psoriasis. The S-phase-specific action of hydroxyurea can deplete bone marrow precursor cells associated with megaloblastic changes.
Dosage:Adults : Solid tumours Intermittent therapy : 80 mg/kg as single dose every 3 rd day. Continuous therapy : 20-30 mg/kg as single daily Dose Carcinoma of head and neck : 80 mg/kg as a single dose every Yd day. Begin therapy atleast 7 days before initiation of irradiation therapy. Resistant chronic myelocytic leukaemia : Continuous therapy of 20-30 mg/kg as a single daily Dose is recommended.
Note: All the provided information about this drug does not substitute for consulting a doctor.